Sammi Dali, MD
Interventional Cardiology · Michigan City, INNPI 1407825722
Payments from drug & device makers
Across 463 payments — averaging $35.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$3K
- Medtronic$2K
- Terumo Medical Corporation$2K
- Abbott$2K
- Johnson & Johnson$989
- Medical Device Business Services, Inc.$790
- plus $6K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 19 | $3,497 |
| Medtronic | 20 | $2,305 |
| Terumo Medical Corporation | 11 | $1,748 |
| Abbott | 15 | $1,542 |
| Johnson & Johnson | 84 | $989 |
| Medical Device Business Services, Inc. | 32 | $790 |
| Novartis | 49 | $743 |
| AstraZeneca | 27 | $499 |
| Boston Scientific | 9 | $497 |
| Amgen | 20 | $474 |
| Esperion Therapeutics, Inc. | 39 | $422 |
| Cook Medical LLC | 12 | $315 |
| E.r. Squibb & Sons, L.L.C. | 8 | $304 |
| Boehringer Ingelheim | 17 | $297 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $252 |
| Pfizer | 11 | $215 |
| Vifor Pharma, Inc. | 10 | $209 |
| Alnylam Pharmaceuticals Inc. | 8 | $195 |
| Edwards Lifesciences | 3 | $168 |
| Kowa Pharmaceuticals America, Inc. | 20 | $168 |
| Abiomed | 1 | $147 |
| Penumbra, Inc. | 1 | $144 |
| Teleflex LLC | 2 | $115 |
| Merck | 8 | $112 |
| Chiesi USA, Inc. | 3 | $100 |
| Actelion Pharmaceuticals US, Inc. | 5 | $86 |
| Regeneron Healthcare Solutions, Inc. | 3 | $53 |
| Sanofi-aventis U.S. LLC | 3 | $47 |
| Cardiovascular Systems Inc. | 2 | $37 |
| Lundbeck LLC | 2 | $35 |
| Amryt Pharma Holdings Ltd | 2 | $30 |
| Gilead | 2 | $26 |
| United Therapeutics Corporation | 1 | $22 |
| Angiodynamics, Inc. | 1 | $16 |
| Bayer | 1 | $14 |
| Shockwave Medical, Inc | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
How this compares
$16,641 in reported general payments places this provider in the 65th percentile of 170 interventional cardiology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Michigan City
- James HermillerIndianapolis$2.8M
- Jithendra ChoudaryRichmond$1.6M
- Jeffrey BreallIndianapolis$955K
- Samer AbbasEast Chicago$625K
- Jarrod FrizzellEvansville$559K
- Brian BigelowIndianapolis$444K
- Saeed ShaikhIndianapolis$366K
- Dean FerreraEast Chicago$298K
- Woodrow CoreyIndianapolis$262K
- Navneet LatherNoblesville$223K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.